Dr. James W. Lynch Jr., MD

Dr. Lynch practices at UF Health Shands Hospital in Gainesville, Florida, part of UF Health.

Dr. Lynch's NPI, 1770524704, was assigned on June 9, 2006. Dr. Lynch graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1984. Dr. Lynch holds Florida license ME46762.

Dr. Lynch's primary practice is UF Health Shands Hospital, at 1600 SW Archer Rd, Gainesville, FL 32610 in Alachua County. The practice phone is (352) 265-8000.

Dr. Lynch's primary practice is UF Health Shands Hospital in Gainesville, Florida, part of UF Health. The medical group on file is UF Health Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lynch practices. Vendor and product names are available with a free account.

Medical oncology is Dr. Lynch's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lynch is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Lynch's licenses on file in 2 states: Florida and Maryland.

Dmand AI lists chronic anemia, chronic leukemia, immune deficiency disease and lymphoma among the conditions Dr. Lynch treats.

CMS data shows 373 Medicare services from Dr. Lynch across 4 procedure codes in 2024, for 157 Medicare patients. Medicare paid $21,317 for them. Every service was in an office.

CMS counts 157 Medicare patients who saw Dr. Lynch in 2024. The largest group is 75 to 84, with 74 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lynch's median patient age at 75, with 52% women.

In 2024, Dr. Lynch wrote 184 Medicare Part D claims for 43 patients. 43% of them were for generic drugs. CMS names the drug for 95 of them, across 3 drugs with 11 or more claims each, at $845,043 in total drug cost. In 2023, CMS named 84 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Lynch for performance year 2024, reported through an alternative payment model (APM). Dr. Lynch accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 52 papers to Dr. Lynch, published from 2005 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Lymphoma, Non-Hodgkin and Hodgkin Disease. Dr. Lynch has published most often in Am J Clin Oncol. Dr. Lynch's most frequent co-authors are Nancy P. Mendenhall, MD, Bradford Scott Hoppe, MD, MPH and Nam Hoang Dang, MD.

CMS Open Payments shows 2 general payments to Dr. Lynch from 2 drug and device companies from 2016 to 2020. Consulting fees make up the largest share, 96% of the total. BeiGene, Ltd. paid the most, $1,650.

Dmand AI lists 28 awards for Dr. Lynch, most recently CMS Stage 1 EHR in 2013.

Dr. Lynch graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 1984. Dr. Lynch is a member of ACP and ASCO.

Dr. Lynch is in network with 16 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.